Te‐Chun Hsia

机构：China Medical University, China Medical University Hospital · ORCID：0000-0003-4297-9918

发表论文 294 篇 · 总被引 7542 次 · h-index 29

代表论文

• Optimal first-line treatment for EGFR-mutated NSCLC: a comparative analysis of osimertinib and second-generation EGFR-TKIs (2024 · BMC Pulmonary Medicine · 被引 7)
• Associations of Matrix Metalloproteinase-7 Promoter Genotypes With Asthma Risk in Taiwan (2025 · In Vivo · 被引 2)
• Significant Contributions of Interleukin-13 Genotypes to Asthma Severity (2025 · In Vivo · 被引 2)
• Impacts of Matrix Metalloproteinase-11 Genotypes on Pterygium Risk (2024 · Anticancer Research · 被引 1)
• From Susceptibility to Disease Severity: Re-Discovering the Clinical Role of MMP-12 Genotypes in Asthma (2026 · Life)
• Supplementary Figure S1 from Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in <i>EGFR</i>-Mutant NSCLC with EGFR Inhibitor Resistance Due to <i>MET</i> Amplification: INSIGHT Final Analysis (2025)